David P French, Jake Southworth, Anthony Howell, Michelle Harvie, Paula Stavrinos, Donna Watterson, Sarah Sampson, D Gareth Evans, Louise S Donnelly. Br J Cancer 2018
Times Cited: 24
Times Cited: 24
Times Cited
Times Co-cited
Similarity
Breast cancer risk feedback to women in the UK NHS breast screening population.
D Gareth R Evans, Louise S Donnelly, Elaine F Harkness, Susan M Astley, Paula Stavrinos, Sarah Dawe, Donna Watterson, Lynne Fox, Jamie C Sergeant, Sarah Ingham,[...]. Br J Cancer 2016
D Gareth R Evans, Louise S Donnelly, Elaine F Harkness, Susan M Astley, Paula Stavrinos, Sarah Dawe, Donna Watterson, Lynne Fox, Jamie C Sergeant, Sarah Ingham,[...]. Br J Cancer 2016
45
A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
37
Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK.
Susanne F Meisel, Nora Pashayan, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. Breast 2015
Susanne F Meisel, Nora Pashayan, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. Breast 2015
33
The WISDOM Study: breaking the deadlock in the breast cancer screening debate.
Laura J Esserman. NPJ Breast Cancer 2017
Laura J Esserman. NPJ Breast Cancer 2017
33
Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
Nora Pashayan, Steve Morris, Fiona J Gilbert, Paul D P Pharoah. JAMA Oncol 2018
Nora Pashayan, Steve Morris, Fiona J Gilbert, Paul D P Pharoah. JAMA Oncol 2018
29
Attitudes towards risk-stratified breast cancer screening among women in England: A cross-sectional survey.
Alex Ghanouni, Saskia C Sanderson, Nora Pashayan, Cristina Renzi, Christian von Wagner, Jo Waller. J Med Screen 2020
Alex Ghanouni, Saskia C Sanderson, Nora Pashayan, Cristina Renzi, Christian von Wagner, Jo Waller. J Med Screen 2020
50
Women's perceptions of the adoption of personalised risk-based breast cancer screening and primary prevention: a systematic review.
Linda Rainey, Daniëlle van der Waal, Yvonne Wengström, Anna Jervaeus, Mireille J M Broeders. Acta Oncol 2018
Linda Rainey, Daniëlle van der Waal, Yvonne Wengström, Anna Jervaeus, Mireille J M Broeders. Acta Oncol 2018
46
Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis.
Ewan Gray, Anna Donten, Nico Karssemeijer, Carla van Gils, D Gareth Evans, Sue Astley, Katherine Payne. Value Health 2017
Ewan Gray, Anna Donten, Nico Karssemeijer, Carla van Gils, D Gareth Evans, Sue Astley, Katherine Payne. Value Health 2017
25
Can Communicating Personalised Disease Risk Promote Healthy Behaviour Change? A Systematic Review of Systematic Reviews.
David P French, Elaine Cameron, Jack S Benton, Christi Deaton, Michelle Harvie. Ann Behav Med 2017
David P French, Elaine Cameron, Jack S Benton, Christi Deaton, Michelle Harvie. Ann Behav Med 2017
25
Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study.
Linda Rainey, Anna Jervaeus, Louise S Donnelly, D Gareth Evans, Mattias Hammarström, Per Hall, Yvonne Wengström, Mireille J M Broeders, Daniëlle van der Waal. Psychooncology 2019
Linda Rainey, Anna Jervaeus, Louise S Donnelly, D Gareth Evans, Mattias Hammarström, Per Hall, Yvonne Wengström, Mireille J M Broeders, Daniëlle van der Waal. Psychooncology 2019
33
Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trials.
Michelle Harvie, Mary Pegington, David French, Grace Cooper, Sarah McDiarmid, Anthony Howell, Louise Donnelly, Helen Ruane, Katharine Sellers, Philip Foden,[...]. BMC Cancer 2019
Michelle Harvie, Mary Pegington, David French, Grace Cooper, Sarah McDiarmid, Anthony Howell, Louise Donnelly, Helen Ruane, Katharine Sellers, Philip Foden,[...]. BMC Cancer 2019
66
What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
David P French, Susan Astley, Adam R Brentnall, Jack Cuzick, Richard Dobrashian, Stephen W Duffy, Louise S Gorman, Elaine F Harkness, Fiona Harrison, Michelle Harvie,[...]. BMC Cancer 2020
David P French, Susan Astley, Adam R Brentnall, Jack Cuzick, Richard Dobrashian, Stephen W Duffy, Louise S Gorman, Elaine F Harkness, Fiona Harrison, Michelle Harvie,[...]. BMC Cancer 2020
50
Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
D Gareth R Evans, Elaine F Harkness, Adam R Brentnall, Elke M van Veen, Susan M Astley, Helen Byers, Sarah Sampson, Jake Southworth, Paula Stavrinos, Sacha J Howell,[...]. Breast Cancer Res Treat 2019
D Gareth R Evans, Elaine F Harkness, Adam R Brentnall, Elke M van Veen, Susan M Astley, Helen Byers, Sarah Sampson, Jake Southworth, Paula Stavrinos, Sacha J Howell,[...]. Breast Cancer Res Treat 2019
20
Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer.
Marie Koitsalu, Mirjam A G Sprangers, Martin Eklund, Kamila Czene, Per Hall, Henrik Grönberg, Yvonne Brandberg. Acta Oncol 2016
Marie Koitsalu, Mirjam A G Sprangers, Martin Eklund, Kamila Czene, Per Hall, Henrik Grönberg, Yvonne Brandberg. Acta Oncol 2016
20
Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
Elke M van Veen, Adam R Brentnall, Helen Byers, Elaine F Harkness, Susan M Astley, Sarah Sampson, Anthony Howell, William G Newman, Jack Cuzick, D Gareth R Evans. JAMA Oncol 2018
Elke M van Veen, Adam R Brentnall, Helen Byers, Elaine F Harkness, Susan M Astley, Sarah Sampson, Anthony Howell, William G Newman, Jack Cuzick, D Gareth R Evans. JAMA Oncol 2018
20
Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.
Paige Maas, Myrto Barrdahl, Amit D Joshi, Paul L Auer, Mia M Gaudet, Roger L Milne, Fredrick R Schumacher, William F Anderson, David Check, Subham Chattopadhyay,[...]. JAMA Oncol 2016
Paige Maas, Myrto Barrdahl, Amit D Joshi, Paul L Auer, Mia M Gaudet, Roger L Milne, Fredrick R Schumacher, William F Anderson, David Check, Subham Chattopadhyay,[...]. JAMA Oncol 2016
20
The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis.
Gareth J Hollands, David P French, Simon J Griffin, A Toby Prevost, Stephen Sutton, Sarah King, Theresa M Marteau. BMJ 2016
Gareth J Hollands, David P French, Simon J Griffin, A Toby Prevost, Stephen Sutton, Sarah King, Theresa M Marteau. BMJ 2016
20
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
Andrew Lee, Nasim Mavaddat, Amber N Wilcox, Alex P Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K Schmidt,[...]. Genet Med 2019
Andrew Lee, Nasim Mavaddat, Amber N Wilcox, Alex P Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K Schmidt,[...]. Genet Med 2019
20
Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
Yiwey Shieh, Martin Eklund, Lisa Madlensky, Sarah D Sawyer, Carlie K Thompson, Allison Stover Fiscalini, Elad Ziv, Laura J Van't Veer, Laura J Esserman, Jeffrey A Tice. J Natl Cancer Inst 2017
Yiwey Shieh, Martin Eklund, Lisa Madlensky, Sarah D Sawyer, Carlie K Thompson, Allison Stover Fiscalini, Elad Ziv, Laura J Van't Veer, Laura J Esserman, Jeffrey A Tice. J Natl Cancer Inst 2017
20
The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
20
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
16
Genetic testing and personalized ovarian cancer screening: a survey of public attitudes.
Susanne F Meisel, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. BMC Womens Health 2016
Susanne F Meisel, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. BMC Womens Health 2016
22
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.
Jack Cuzick, Ivana Sestak, Bernardo Bonanni, Joseph P Costantino, Steve Cummings, Andrea DeCensi, Mitch Dowsett, John F Forbes, Leslie Ford, Andrea Z LaCroix,[...]. Lancet 2013
Jack Cuzick, Ivana Sestak, Bernardo Bonanni, Joseph P Costantino, Steve Cummings, Andrea DeCensi, Mitch Dowsett, John F Forbes, Leslie Ford, Andrea Z LaCroix,[...]. Lancet 2013
16
The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
A C Antoniou, P P D Pharoah, P Smith, D F Easton. Br J Cancer 2004
A C Antoniou, P P D Pharoah, P Smith, D F Easton. Br J Cancer 2004
16
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey,[...]. Br J Cancer 2008
A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey,[...]. Br J Cancer 2008
16
'A low risk is still a risk': exploring women's attitudes towards genetic testing for breast cancer susceptibility in order to target disease prevention.
L Henneman, D R Timmermans, C M Bouwman, M C Cornel, H Meijers-Heijboer. Public Health Genomics 2011
L Henneman, D R Timmermans, C M Bouwman, M C Cornel, H Meijers-Heijboer. Public Health Genomics 2011
16
Incorporating genomics into breast and prostate cancer screening: assessing the implications.
Susmita Chowdhury, Tom Dent, Nora Pashayan, Alison Hall, Georgios Lyratzopoulos, Nina Hallowell, Per Hall, Paul Pharoah, Hilary Burton. Genet Med 2013
Susmita Chowdhury, Tom Dent, Nora Pashayan, Alison Hall, Georgios Lyratzopoulos, Nina Hallowell, Per Hall, Paul Pharoah, Hilary Burton. Genet Med 2013
16
Are we ready for the challenge of implementing risk-based breast cancer screening and primary prevention?
Linda Rainey, Daniëlle van der Waal, Anna Jervaeus, Yvonne Wengström, D Gareth Evans, Louise S Donnelly, Mireille J M Broeders. Breast 2018
Linda Rainey, Daniëlle van der Waal, Anna Jervaeus, Yvonne Wengström, D Gareth Evans, Louise S Donnelly, Mireille J M Broeders. Breast 2018
25
Assessing and managing breast cancer risk: clinicians' current practice and future needs.
Ian M Collins, Emma Steel, G Bruce Mann, Jon D Emery, Adrian Bickerstaffe, Alison Trainer, Phyllis Butow, Marie Pirotta, Antonis C Antoniou, Jack Cuzick,[...]. Breast 2014
Ian M Collins, Emma Steel, G Bruce Mann, Jon D Emery, Adrian Bickerstaffe, Alison Trainer, Phyllis Butow, Marie Pirotta, Antonis C Antoniou, Jack Cuzick,[...]. Breast 2014
16
Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention.
D Gareth Evans, Adam R Brentnall, Michelle Harvie, Sarah Dawe, Jamie C Sergeant, Paula Stavrinos, Susan Astley, Mary Wilson, John Ainsworth, Jack Cuzick,[...]. Cancer Prev Res (Phila) 2014
D Gareth Evans, Adam R Brentnall, Michelle Harvie, Sarah Dawe, Jamie C Sergeant, Paula Stavrinos, Susan Astley, Mary Wilson, John Ainsworth, Jack Cuzick,[...]. Cancer Prev Res (Phila) 2014
19
Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
Linda Rainey, Daniëlle van der Waal, Louise S Donnelly, D Gareth Evans, Yvonne Wengström, Mireille Broeders. PLoS One 2018
Linda Rainey, Daniëlle van der Waal, Louise S Donnelly, D Gareth Evans, Yvonne Wengström, Mireille Broeders. PLoS One 2018
23
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
Adam R Brentnall, Elaine F Harkness, Susan M Astley, Louise S Donnelly, Paula Stavrinos, Sarah Sampson, Lynne Fox, Jamie C Sergeant, Michelle N Harvie, Mary Wilson,[...]. Breast Cancer Res 2015
Adam R Brentnall, Elaine F Harkness, Susan M Astley, Louise S Donnelly, Paula Stavrinos, Sarah Sampson, Lynne Fox, Jamie C Sergeant, Michelle N Harvie, Mary Wilson,[...]. Breast Cancer Res 2015
16
How Do Women View Risk-Based Mammography Screening? A Qualitative Study.
Xiaofei He, Karen E Schifferdecker, Elissa M Ozanne, Anna N A Tosteson, Steven Woloshin, Lisa M Schwartz. J Gen Intern Med 2018
Xiaofei He, Karen E Schifferdecker, Elissa M Ozanne, Anna N A Tosteson, Steven Woloshin, Lisa M Schwartz. J Gen Intern Med 2018
28
Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
Nora Pashayan, Antonis C Antoniou, Urska Ivanus, Laura J Esserman, Douglas F Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans,[...]. Nat Rev Clin Oncol 2020
Nora Pashayan, Antonis C Antoniou, Urska Ivanus, Laura J Esserman, Douglas F Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans,[...]. Nat Rev Clin Oncol 2020
16
Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification.
Parichoy Pal Choudhury, Amber N Wilcox, Mark N Brook, Yan Zhang, Thomas Ahearn, Nick Orr, Penny Coulson, Minouk J Schoemaker, Michael E Jones, Mitchell H Gail,[...]. J Natl Cancer Inst 2020
Parichoy Pal Choudhury, Amber N Wilcox, Mark N Brook, Yan Zhang, Thomas Ahearn, Nick Orr, Penny Coulson, Minouk J Schoemaker, Michael E Jones, Mitchell H Gail,[...]. J Natl Cancer Inst 2020
16
Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.
Ester Vilaprinyo, Carles Forné, Misericordia Carles, Maria Sala, Roger Pla, Xavier Castells, Laia Domingo, Montserrat Rue. PLoS One 2014
Ester Vilaprinyo, Carles Forné, Misericordia Carles, Maria Sala, Roger Pla, Xavier Castells, Laia Domingo, Montserrat Rue. PLoS One 2014
16
10-year performance of four models of breast cancer risk: a validation study.
Mary Beth Terry, Yuyan Liao, Alice S Whittemore, Nicole Leoce, Richard Buchsbaum, Nur Zeinomar, Gillian S Dite, Wendy K Chung, Julia A Knight, Melissa C Southey,[...]. Lancet Oncol 2019
Mary Beth Terry, Yuyan Liao, Alice S Whittemore, Nicole Leoce, Richard Buchsbaum, Nur Zeinomar, Gillian S Dite, Wendy K Chung, Julia A Knight, Melissa C Southey,[...]. Lancet Oncol 2019
16
Consumer and clinician perspectives on personalising breast cancer prevention information.
L A Keogh, E Steel, P Weideman, P Butow, I M Collins, J D Emery, G B Mann, A Bickerstaffe, A H Trainer, L J Hopper,[...]. Breast 2019
L A Keogh, E Steel, P Weideman, P Butow, I M Collins, J D Emery, G B Mann, A Bickerstaffe, A H Trainer, L J Hopper,[...]. Breast 2019
40
Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders' views on a low-risk breast screening pathway.
Lorna McWilliams, Victoria G Woof, Louise S Donnelly, Anthony Howell, D Gareth Evans, David P French. BMC Cancer 2020
Lorna McWilliams, Victoria G Woof, Louise S Donnelly, Anthony Howell, D Gareth Evans, David P French. BMC Cancer 2020
44
Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.
Timothy R Rebbeck, Noah D Kauff, Susan M Domchek. J Natl Cancer Inst 2009
Timothy R Rebbeck, Noah D Kauff, Susan M Domchek. J Natl Cancer Inst 2009
12
Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population.
Ranjit Manchanda, Oleg Blyuss, Faiza Gaba, Vladimir Sergeevich Gordeev, Chris Jacobs, Matthew Burnell, Carmen Gan, Rohan Taylor, Clare Turnbull, Rosa Legood,[...]. J Med Genet 2018
Ranjit Manchanda, Oleg Blyuss, Faiza Gaba, Vladimir Sergeevich Gordeev, Chris Jacobs, Matthew Burnell, Carmen Gan, Rohan Taylor, Clare Turnbull, Rosa Legood,[...]. J Med Genet 2018
12
Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility.
Simone M Rowley, Lyon Mascarenhas, Lisa Devereux, Na Li, Kaushalya C Amarasinghe, Magnus Zethoven, Jue Er Amanda Lee, Alexandra Lewis, James A Morgan, Sharne Limb,[...]. Genet Med 2019
Simone M Rowley, Lyon Mascarenhas, Lisa Devereux, Na Li, Kaushalya C Amarasinghe, Magnus Zethoven, Jue Er Amanda Lee, Alexandra Lewis, James A Morgan, Sharne Limb,[...]. Genet Med 2019
12
Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis.
Ranjit Manchanda, Rosa Legood, Antonis C Antoniou, Vladimir S Gordeev, Usha Menon. J Med Genet 2016
Ranjit Manchanda, Rosa Legood, Antonis C Antoniou, Vladimir S Gordeev, Usha Menon. J Med Genet 2016
12
Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.
Ranjit Manchanda, Kelly Loggenberg, Saskia Sanderson, Matthew Burnell, Jane Wardle, Sue Gessler, Lucy Side, Nyala Balogun, Rakshit Desai, Ajith Kumar,[...]. J Natl Cancer Inst 2014
Ranjit Manchanda, Kelly Loggenberg, Saskia Sanderson, Matthew Burnell, Jane Wardle, Sue Gessler, Lucy Side, Nyala Balogun, Rakshit Desai, Ajith Kumar,[...]. J Natl Cancer Inst 2014
12
Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations.
Ranjit Manchanda, Matthew Burnell, Kelly Loggenberg, Rakshit Desai, Jane Wardle, Saskia C Sanderson, Sue Gessler, Lucy Side, Nyala Balogun, Ajith Kumar,[...]. J Med Genet 2016
Ranjit Manchanda, Matthew Burnell, Kelly Loggenberg, Rakshit Desai, Jane Wardle, Saskia C Sanderson, Sue Gessler, Lucy Side, Nyala Balogun, Ajith Kumar,[...]. J Med Genet 2016
12
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
Ranjit Manchanda, Rosa Legood, Matthew Burnell, Alistair McGuire, Maria Raikou, Kelly Loggenberg, Jane Wardle, Saskia Sanderson, Sue Gessler, Lucy Side,[...]. J Natl Cancer Inst 2014
Ranjit Manchanda, Rosa Legood, Matthew Burnell, Alistair McGuire, Maria Raikou, Kelly Loggenberg, Jane Wardle, Saskia Sanderson, Sue Gessler, Lucy Side,[...]. J Natl Cancer Inst 2014
12
Setting the Threshold for Surgical Prevention in Women at Increased Risk of Ovarian Cancer.
Ranjit Manchanda, Usha Menon. Int J Gynecol Cancer 2018
Ranjit Manchanda, Usha Menon. Int J Gynecol Cancer 2018
23
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.
Ranjit Manchanda, Shreeya Patel, Antonis C Antoniou, Ephrat Levy-Lahad, Clare Turnbull, D Gareth Evans, John L Hopper, Robert J Macinnis, Usha Menon, Ian Jacobs,[...]. Am J Obstet Gynecol 2017
Ranjit Manchanda, Shreeya Patel, Antonis C Antoniou, Ephrat Levy-Lahad, Clare Turnbull, D Gareth Evans, John L Hopper, Robert J Macinnis, Usha Menon, Ian Jacobs,[...]. Am J Obstet Gynecol 2017
12
Impact of a decision aid about stratified ovarian cancer risk-management on women's knowledge and intentions: a randomised online experimental survey study.
Susanne F Meisel, Maddie Freeman, Jo Waller, Lindsay Fraser, Sue Gessler, Ian Jacobs, Jatinderpal Kalsi, Ranjit Manchanda, Belinda Rahman, Lucy Side,[...]. BMC Public Health 2017
Susanne F Meisel, Maddie Freeman, Jo Waller, Lindsay Fraser, Sue Gessler, Ian Jacobs, Jatinderpal Kalsi, Ranjit Manchanda, Belinda Rahman, Lucy Side,[...]. BMC Public Health 2017
42
Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women.
Ranjit Manchanda, Rosa Legood, Leigh Pearce, Usha Menon. Gynecol Oncol 2015
Ranjit Manchanda, Rosa Legood, Leigh Pearce, Usha Menon. Gynecol Oncol 2015
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.